Positron Emission Tomography

Positron emission releases a positron from the radionuclide, and that positron subsequently annihilates with an electron. The event produces two gamma photons traveling in opposing directions. PET detectors register the photons as a coincidence, providing paired detection information that supports reconstruction of where the labeled molecule is distributed within the organism.

The labeled molecule determines which physiological process the scan can represent. Molecules associated with glucose metabolism, blood flow, receptor binding, or cellular proliferation produce information about those specific biological activities. Consequently, tracer distribution must be interpreted in relation to the molecule’s biological role rather than treated as a nonspecific measure of tissue structure.

PET contributes functional information about physiological activity, whereas MRI and CT primarily support anatomical assessment. Comparing these modalities can relate an active biological process to the structures in which it occurs. This distinction helps researchers investigate disease progression, brain function, cancer biology, and cardiovascular processes more comprehensively than either functional or anatomical imaging alone.

A PET workflow introduces a biologically active molecule labeled with a positron-emitting radionuclide into the living organism. The radionuclide emits positrons, annihilation generates opposing gamma photons, and detectors record coincident photons. Computational reconstruction then maps tracer distribution, producing quantitative images that can be used to evaluate the selected physiological process in vivo.

PET can measure several functional processes, including glucose metabolism, blood flow, receptor binding, and cellular proliferation. These readouts allow researchers to examine how tissues operate rather than only how they appear anatomically. In biology and biomedical research, the approach supports investigations of normal function, altered physiology, drug action, and disease-related changes.

PET is useful when researchers need quantitative, noninvasive measurements of physiology in living organisms. It supports studies of brain function, cancer biology, cardiovascular disease, drug action, and disease progression. Because measurements can be repeated in vivo, investigators can follow functional changes over time while limiting the need for invasive sampling.